Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNY1 pseudogene 8 (RNY1P8) is a human gene classified as a pseudogene, specifically one related to the Ro-associated Y1 RNA family. Pseudogenes are genomic DNA sequences similar to normal genes but typically nonfunctional; they often lack regulatory regions or protein-coding capability, and, while they may be transcribed into RNA, they rarely produce functional products. Some pseudogenes (not specifically RNY1P8) are implicated in regulatory functions, such as serving as decoys for microRNAs or producing regulatory RNAs, but no functional or disease role is documented for RNY1P8 itself. RNY1P8 is not considered a therapeutic target, and there are no known drug interactions or safety/treatment implications related to this gene. Clarification: - There are several reports in the search results about another pseudogene, "Double homeobox A pseudogene 8 (DUXAP8)," a long non-coding RNA with roles in cancer, but this is unrelated to RNY1P8. - No evidence was found that RNY1P8 participates in major regulatory functions or disease processes, nor that it is targeted by any drugs. - The gene's main distinguishing feature is its identity as a nonfunctional, pseudogenic copy of the Ro-associated Y1 gene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNY1 pseudogene 8 (RNY1P8).